Search ARM

Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, in particular primary immunodeficiencies and inherited metabolic diseases. Based in Milan, Italy, Genespire was founded in March 2020 as a spin-off of SR-Tiget, one of the world leading cell and gene therapy research institutes, by gene therapy pioneer Luigi Naldini, Alessio Cantore, Fondazione Telethon, Ospedale San Raffaele, and backed by Sofinnova Partners.

Contact Genespire
Visit Website